Abstract
The driver mutations in exon 9 of the calreticulin protein have only been identified in patients with myeloid cancers. We recently demonstrated that healthy individuals display strong and frequent T-cell responses towards this mutation. This memory T-cell response is likely evidence of the elimination of mutated cells in healthy individuals.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 1599640 |
Tidsskrift | OncoImmunology |
Vol/bind | 8 |
Udgave nummer | 7 |
Antal sider | 2 |
ISSN | 2162-4011 |
DOI | |
Status | Udgivet - 2019 |